176
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Ultrasound protocols to measure carotid intima–media thickness: a post-hoc analysis of the OPAL study*

, , , , , & show all
Pages 109-122 | Accepted 30 Oct 2008, Published online: 27 Nov 2008
 

ABSTRACT

Objective: Ultrasound protocols to measure carotid intima–media thickness (CIMT) differ in the number of carotid walls, segments and angles measured. No published evidence is available to help decide which approach is best, i.e. the most reproducible and providing the largest CIMT progression rate measured with highest precision. We compared different ultrasound protocols in a post-hoc analysis in the ‘Osteoporosis Prevention and Arterial effects of tiboLone’ (OPAL) study, a 3-year randomized controlled trial among healthy postmenopausal women.

Research design and methods: Based on combinations of 60 CIMT measurements per participant (two sides, two walls, three segments, five angles), 66 theoretical protocols were constructed. Each protocol was assessed and ranked on: (1) reproducibility (intra-class correlation (ICC), mean difference of duplicate scans) and (2) CIMT progression rate and its precision (standard error) in the placebo group.

Results: Duplicate scans at baseline and end of study were available for 675 women (89% of 759 subjects). ICC ranged from 0.69 to 0.88. Mean difference in CIMT of duplicate scans and its standard deviation, ranged from 0.0010 to 0.0137 mm and from 0.0561 to 0.1770, respectively. CIMT rate of progression ranged from –0.0001 to 0.0113 mm/year. The protocols with highest reproducibility and highest CIMT progression-precision were mean common CIMT protocols measuring both near and far wall at ≥ 2 angles. The mean maximum protocol measuring three segments at ≥ 2 angles performed best, yet with lower estimates as for common CIMT protocols.

Conclusions: In healthy middle-aged subjects mean common CIMT protocols that include measurements at both near and far walls at multiple (≥ 2) angles provide highest reproducibility combined with largest estimates of CIMT progression measured with high precision and are to be recommended in this population.

Acknowledgements

Declaration of interest: The OPAL study was supported by a grant from NV Organon (No. 32947). The sponsors have had no role in the preparation of this article. S. Dogan and Y. Plantinga have no conflicts of interest related to the contents of this article. M. L. Bots and D. E. Grobbee have received study grants from and have acted as consultants for Organon NV. G. W. Evans has received study grants from Organon Inc. and has acted as a consultant. R. Meijer owns the patents on the rights to use the Meijers Carotid Arc and is currently an employee of Bio-Imaging Technologies.

The authors acknowledge contributions to the design and the conduct of the OPAL study from the late Dr Ward Riley, PhD.

Notes

* These results were presented at the 48th Cardiovascular Disease Epidemiology and Prevention Conference, and Nutrition, Physical Activity and Metabolism Conference, March 13–15, 2008, Colorado Springs, CO, USA

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.